Log in
Enquire now
Radiant Biotherapeutics

Radiant Biotherapeutics

Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody

OverviewStructured DataIssuesContributors

Contents

radiantbio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Therapeutics
Therapeutics
Location
Toronto, Ontario, Canada
Toronto, Ontario, Canada
B2X
B2B
B2B
CEO
‌
Art Fratamico
Number of Employees (Ranges)
1 – 10
Investors
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Alexandria Venture Investments
Alexandria Venture Investments
Facit (Fight Against Cancer Innovation Trust)
Facit (Fight Against Cancer Innovation Trust)
Toronto Innovation Acceleration Partners (TIAP)
Toronto Innovation Acceleration Partners (TIAP)
‌
Amplitude Venture Capital
BDC Capital Corporation
BDC Capital Corporation
Total Funding Amount (USD)
35,000,000
Latest Funding Round Date
September 11, 2024
Latest Funding Type
Series A
Series A

Other attributes

Latest Funding Round Amount (USD)
35,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Radiant Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.